How ARC is Using New Eye Screening Technology to Prevent Blindness Disease

ARC CEO Dr. Anas Daghestani Discusses the New Prevention Tool with Local News KXAN-TV

Less than half of diabetic adults do not get their annual eye screening, putting them at risk for diabetic retinopathy, one of the leading causes of blindness in the U.S.

ARC knew it could do better. That is why we brought the screening technology to our patients.

In just nine months, the results have been outstanding.

Learn about how ARC helped a young website developer and music hobbyist save his vision on KXAN-TV.

Using Technology to Improve Access
“In the course of diabetes, you really just need to keep up with staying active, keep up with your doctor appointments,” explained Dr. Anas Daghestani, ARC CEO and Medical Director of Population Health & Clinical Quality. “But later in the disease you have to worry about your eyes, you have to worry about your kidneys, about your heart – so it can get overwhelming between all the doctor’s appointments.”

He also said that because diabetic retinopathy carries few symptoms, many are unaware they have the disease until it’s too late to treat.

That is why ARC decided to bring the screening to patients by embedding IRIS® eye screening technology at three clinics in 2015. The specialized cameras take precise images of the retina and send them seamlessly and securely to local retina specialists to review. If a test comes back abnormal, the patient is recommend to follow up with an ophthalmologist.

The results were excellent — more people were getting screened and early stages of the eye disease were being detected. ARC has since added the technology at three more clinics with plans to add more.

From the Eyes of a Patient
When Demetrius Kellum lost his wife unexpectedly in 2014, his health also took a tumble. At a regular visit with his family medicine physician, Dr. Vanessa Ven Huizen, she suggested getting an eye screening on the way out. He did...and his eyesight was likely saved because of it.

Demetrius was diagnosed with non-proliferative diabetic retinopathy, an early stage of the disease and was immediately referred to a retinal specialist at Austin Retina Associates . After three months of eye injections, today are almost no traces of the disease. Read more about Demetrius’ story.

Said Demetrius in an interview with KXAN, “My eyesight, it’s a lot better. I’m glad I have it. I couldn’t do my daily job and I couldn’t do my hobby at all.”

Learn more about the new eye screening technology at Austin Regional Clinic.

Tags: Dr. Anas Daghestani, Diabetic retinopathy, diabetes, KXAN

More on this Topic

ARC’s successful Diabetic Retinal Screening program featured in national publication

The new IRIS (Intelligent Retinal Imaging Systems) program currently screening diabetes patients in three ARC clinics has received recognition in Ophthalmology Management, an online industry publication. Dr. Anas Daghestani, Chief of ARC Internal Medicine and Director of Population Health and Clinical Quality, explains how and why the program has been successful in “helping to prevent the preventable” eye disease.

A 5-minute scan can save your eyesight

Diabetic retinopathy is the leading cause of blindness in all adults under the age of 75 but it is also detectable and treatable. ARC has a vision-saving scan.

In-Office Eye Screening Leads to Improved Diabetic Eye Health

Stella N., who has been an ARC patient since 2002, was diagnosed with diabetes in the 1980's. In 2015, when she saw her regular ARC physician, Dr. Sharon Liu, Stella expected to be referred to an ophthalmologist for an eye screening but she got a surprise. 

New Screening Saves Vision, Prevents Blindness

Diabetic retinopathy is the leading cause of blindness in the U.S., but has few early symptoms. You can now get a retinal eye screening at your next visit.

ARC Diabetic Patients to Benefit From New Eye Screening Technology

ARC has installed eye screening telemedicine technology at three of its locations to help prevent the eye disease known as diabetic retinopathy, the leading cause of blindness among U.S. adults. The goal is simple…identify disease symptoms early and prevent blindness by making it convenient for patients to access eye screenings. It’s what’s right for our patients.